The company is seeking authorisation for a fourth dose of SpikeVax to any adult who has received an initial booster of any of the authorised or approved COVID-19 vaccines. Unlike Pfizer ...

Concerns about the COVID-19 shots have increased after a report that drug maker Moderna failed to inform the U.S. government of the death of a child during clinical trials ...

The booster shot – called mRNA-1273.211 ... be good to see data from studies of other variant vaccine boosters to compare to the Moderna combination. Expert advisors "must already be thinking ...

The third scenario, in which the booster dose was with the Pfizer vaccine, showed the highest percentages of effectiveness: 56.8% against symptomatic infections and 85.5% against severe cases.

A number of High Street chemists and private clinics sell and administer the Pfizer Covid vaccine directly to the public. The ...

Dr. Adam Ratner joins Morning Joe to discuss his new book 'Booster Shots: The Urgent Lessons of Measles and the Uncertain Future of Children's Health'.

Additionally, vaccines with similar technology show that antibodies can migrate: For instance, with Moderna’s Covid-19 vaccine, antibodies are shown to move to sites of infection in the nose.

Six deaths reported this past week in McLeod County were attributed to COVID-19, according to data from the Minnesota Department of Health. It was the deadliest week of the pandemic since last ...

More than 1,000 people who have sought support from the vaccine damage payment scheme after being injured or bereaved as a ...

The U.S. government has handed Moderna almost $600 million to accelerate its work on various bird flu vaccines as well as work on mRNA vaccines for other influenza strains with pandemic potential.

Moderna launched its RSV vaccine last year, following earlier approved vaccines from Pfizer (PFE) and GSK (GSK). A health worker prepares a Moderna COVID-19 vaccine at a vaccination center.

Moderna Inc. shares plunged after the company slashed its sales forecast for this year as it struggles with slow demand for its Covid and RSV vaccines. The Cambridge, Massachusetts-based company ...